{"id":30200,"date":"2025-03-24T17:16:05","date_gmt":"2025-03-24T16:16:05","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=30200"},"modified":"2025-03-26T14:26:10","modified_gmt":"2025-03-26T13:26:10","slug":"lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/","title":{"rendered":"L\u2019association d\u2019antibiotique ceftazidime-avibactam est efficace et bien tol\u00e9r\u00e9e selon une \u00e9tude observationnelle fran\u00e7aise"},"content":{"rendered":"\n<p>L\u2019\u00e9tude observationnelle OZAVIE publi\u00e9e r\u00e9cemment confirme que l\u2019association ceftazidime-avibactam (CAZ-AVI) est efficace avec un taux de succ\u00e8s clinique allant de 63,4% \u00e0 79%, dans le traitement des infections \u00e0 Grams n\u00e9gatifs, multi-r\u00e9sistants (MDR-GNB). Ces taux augmentent de 65,6% \u00e0 81,7% lorsque l\u2019on \u00e9tudie la r\u00e9ponse clinique au traitement des infections \u00e0 P.aeruginosa par bith\u00e9rapie. Par ailleurs, l\u2019\u00e9tude met en lumi\u00e8re le bon profil de s\u00e9curit\u00e9 de l\u2019association avec 17,4% des effets ind\u00e9sirables possiblement imputables dont seulement 6,2% graves. Aussi, l\u2019\u00e9tude renforce le r\u00f4le du CAZ-AVI dans la strat\u00e9gie th\u00e9rapeutique des infections MDR-GNB tout en soulevant la n\u00e9cessit\u00e9 d&#8217;en \u00e9valuer l&#8217;impact \u00e9cologique \u00e0 l\u2019occasion de futures recherches.<\/p>\n\n\n\n<div class=\"wp-block-columns are-vertically-aligned-bottom is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-bottom is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure data-wp-context=\"{&quot;uploadedSrc&quot;:&quot;https:\\\/\\\/ppr-antibioresistance.inserm.fr\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/Capture-decran-2025-03-26-103550.png&quot;,&quot;figureClassNames&quot;:&quot;wp-block-image size-large&quot;,&quot;figureStyles&quot;:null,&quot;imgClassNames&quot;:&quot;wp-image-30216&quot;,&quot;imgStyles&quot;:null,&quot;targetWidth&quot;:795,&quot;targetHeight&quot;:1060,&quot;scaleAttr&quot;:false,&quot;ariaLabel&quot;:&quot;Agrandir l\\u2018image&quot;,&quot;alt&quot;:&quot;&quot;}\" data-wp-interactive=\"core\/image\" class=\"wp-block-image size-large wp-lightbox-container\"><img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"1024\" data-wp-init=\"callbacks.setButtonStyles\" data-wp-on--click=\"actions.showLightbox\" data-wp-on--load=\"callbacks.setButtonStyles\" data-wp-on-window--resize=\"callbacks.setButtonStyles\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\" alt=\"\" class=\"wp-image-30216\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png 768w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-225x300.png 225w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550.png 795w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/><button\n\t\t\tclass=\"lightbox-trigger\"\n\t\t\ttype=\"button\"\n\t\t\taria-haspopup=\"dialog\"\n\t\t\taria-label=\"Agrandir l\u2018image\"\n\t\t\tdata-wp-init=\"callbacks.initTriggerButton\"\n\t\t\tdata-wp-on--click=\"actions.showLightbox\"\n\t\t\tdata-wp-style--right=\"context.imageButtonRight\"\n\t\t\tdata-wp-style--top=\"context.imageButtonTop\"\n\t\t>\n\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"12\" height=\"12\" fill=\"none\" viewBox=\"0 0 12 12\">\n\t\t\t\t<path fill=\"#fff\" d=\"M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z\" \/>\n\t\t\t<\/svg>\n\t\t<\/button><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-bottom is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><strong>Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIE<\/strong><\/p>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-width wp-block-button__width-25 has-custom-font-size is-style-outline has-small-font-size\"><a class=\"wp-block-button__link has-luminous-vivid-orange-color has-text-color has-link-color wp-element-button\" href=\"https:\/\/pdf.sciencedirectassets.com\/778420\/1-s2.0-S2666991925X00026\/1-s2.0-S2666991925000156\/main.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEJT%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJIMEYCIQDmII1mOcYJnYFQ8XmF2INCTKGjSUIsnhXOSINeaGcn8QIhAMVEAGH4WM9CX3Zbl72IDxlpE%2B2qhEL7np1J6I6K%2F2fbKrwFCO3%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQBRoMMDU5MDAzNTQ2ODY1IgwWHqrT2NCjsHUswXYqkAWQirMGPwIXr5s4NHCSSuTwnC%2Biyi1ROZ7Qajj8mFDpYuXIz3JueI4ehKJD%2FGwRC68r6I227kZ9FJE0ieOzPSAgixDG%2BB8rlY6gEnARX7GFrHu%2BXQCNqw8G0USLyUjZxHbaFBYvSPGSiCydIE4QgIJviXLu%2FfAzQcyPw%2B0FXn%2Fl8%2FcJAv%2BMd%2FTepBrScu8cSU69zDsKcoQ1CMMw0CxFQa%2Fo0XZZYSmP%2FoGg%2BzD20ZHjueLxx19Ct0QopFb04UBZkfoNFHQsqFEhek0I%2Bx6zWRg86HauXALm4Dm4IuwZGtosROuYs%2BGg3TAEeFMg4xHQjDvF%2FTye6gn4ia0oXCj8reyhIgHPi5epxY0hnUPwJV1tmFBas6c4RFJFIN3xmvmXvB38cR4kKb8MU1LN0kvlNh4lhmN6RbxlKUluq9WvTmOU2%2BCx4%2FAOfWwOZk%2FlF%2FmzAYktHWXuVkxMiSu42G0lz16QW45cUTSWHA31axJjRJ7JalvrGg08sDVBLhKBx2BDoLAzc12ZQw8rkuuwyvNuH%2FQvwW25m%2BUSGBwDdQRJz45vfsmOr6SMUw72QOndX718M5i8CyxDBL68zhuDyW96ibkty15T6%2BBGdIpqz%2F4T81Vc8ISZZfJzLIrVTzwq5MoLFWSNDqDW0fAVqWEuDkLjHLjcFkpMVTIDmV5iUANTr7qbde2k7rMjHDr%2BLXxAvob7fKE96IHQnPgn3dtO%2FYkT8npFniCT3t4wHz3ZVIRf0gaFvxEc6MpgLMiP%2FgpDrFmfHPxS%2FQbkILYYPXEeql%2FghlqqvyE7qXMOXvI5rpAd6pKTzidzQXszFa9JLq4EHvLz0xmwKcySdOGSXdvT8iQCUhiRUT7mQJSB9MtBjDs%2BLuHeYDD%2Fj4W%2FBjqwAejLqjI96FhGHMYybHit8bzKJT22T3A12P44NnZ2D%2FXF1KnwS39ukfuSMocNjpwA3NAPDi13yhnX8FdzVb5AofkQL8QwWm%2FrKOzzPnuuDc7BJzU2DZCbgHRNoqU%2BNru0hE3M0W6dU8t%2F30CpNXsgo4jENmunwXIGH6II1EVyg6nsnBd5OkfnJESSwY2aBK78w5QDBHAaVAtlcN8GP24tT%2F3xDGUOF3UfZHDSLG1QJtyW&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20250324T130150Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Expires=300&amp;X-Amz-Credential=ASIAQ3PHCVTYZCDJ7MMZ%2F20250324%2Fus-east-1%2Fs3%2Faws4_request&amp;X-Amz-Signature=ed4e987f0966cd819494069cbaaaec38ad82ffab8b41881847112f5d23aa4116&amp;hash=253619d269c1901ce5bb0b923b47f72c8cb44a37bc4b836aa67e83a5d54b6633&amp;host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61&amp;pii=S2666991925000156&amp;tid=spdf-9501deec-97a7-4bb9-b0f2-5a99a9397671&amp;sid=d849fd98263b08416b0b5e78f22f92b8db54gxrqb&amp;type=client&amp;tsoh=d3d3LnNjaWVuY2VkaXJlY3QuY29t&amp;rh=d3d3LnNjaWVuY2VkaXJlY3QuY29t&amp;ua=1c14575155565702545402&amp;rr=92565c02fdc0d5cd&amp;cc=fr\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Cliquez ici<\/strong><\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019\u00e9tude observationnelle OZAVIE publi\u00e9e r\u00e9cemment confirme que l\u2019association ceftazidime-avibactam (CAZ-AVI) est efficace avec un taux de succ\u00e8s clinique allant de 63,4% \u00e0 79%, dans le traitement des infections \u00e0 Grams n\u00e9gatifs, multi-r\u00e9sistants (MDR-GNB). Ces taux augmentent de 65,6% \u00e0 81,7% lorsque l\u2019on \u00e9tudie la r\u00e9ponse clinique au traitement des infections \u00e0 P.aeruginosa par bith\u00e9rapie. Par ailleurs, l\u2019\u00e9tude met en lumi\u00e8re le bon profil de s\u00e9curit\u00e9 de l\u2019association avec 17,4% des effets ind\u00e9sirables possiblement imputables dont seulement 6,2% graves. Aussi, l\u2019\u00e9tude renforce le r\u00f4le du CAZ-AVI dans la strat\u00e9gie th\u00e9rapeutique des infections MDR-GNB tout en soulevant la n\u00e9cessit\u00e9 d&#8217;en \u00e9valuer l&#8217;impact \u00e9cologique \u00e0 l\u2019occasion de futures recherches.<\/p>\n","protected":false},"author":275,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,26],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L\u2019association d\u2019antibiotique ceftazidime-avibactam est efficace et bien tol\u00e9r\u00e9e selon une \u00e9tude observationnelle fran\u00e7aise - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019association d\u2019antibiotique ceftazidime-avibactam est efficace et bien tol\u00e9r\u00e9e selon une \u00e9tude observationnelle fran\u00e7aise - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-24T16:16:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-26T13:26:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\" \/>\n<meta name=\"author\" content=\"supportmlcom\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"supportmlcom\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/\"},\"author\":{\"name\":\"supportmlcom\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5\"},\"headline\":\"L\u2019association d\u2019antibiotique ceftazidime-avibactam est efficace et bien tol\u00e9r\u00e9e selon une \u00e9tude observationnelle fran\u00e7aise\",\"datePublished\":\"2025-03-24T16:16:05+00:00\",\"dateModified\":\"2025-03-26T13:26:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/\"},\"wordCount\":150,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\",\"articleSection\":[\"Actualit\u00e9s\",\"Infos pratiques &amp; communications\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/\",\"name\":\"L\u2019association d\u2019antibiotique ceftazidime-avibactam est efficace et bien tol\u00e9r\u00e9e selon une \u00e9tude observationnelle fran\u00e7aise - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\",\"datePublished\":\"2025-03-24T16:16:05+00:00\",\"dateModified\":\"2025-03-26T13:26:10+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"L\u2019association d\u2019antibiotique ceftazidime-avibactam est efficace et bien tol\u00e9r\u00e9e selon une \u00e9tude observationnelle fran\u00e7aise\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5\",\"name\":\"supportmlcom\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019association d\u2019antibiotique ceftazidime-avibactam est efficace et bien tol\u00e9r\u00e9e selon une \u00e9tude observationnelle fran\u00e7aise - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/","og_locale":"fr_FR","og_type":"article","og_title":"L\u2019association d\u2019antibiotique ceftazidime-avibactam est efficace et bien tol\u00e9r\u00e9e selon une \u00e9tude observationnelle fran\u00e7aise - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2025-03-24T16:16:05+00:00","article_modified_time":"2025-03-26T13:26:10+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png"}],"author":"supportmlcom","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"supportmlcom","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/"},"author":{"name":"supportmlcom","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5"},"headline":"L\u2019association d\u2019antibiotique ceftazidime-avibactam est efficace et bien tol\u00e9r\u00e9e selon une \u00e9tude observationnelle fran\u00e7aise","datePublished":"2025-03-24T16:16:05+00:00","dateModified":"2025-03-26T13:26:10+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/"},"wordCount":150,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png","articleSection":["Actualit\u00e9s","Infos pratiques &amp; communications"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/","name":"L\u2019association d\u2019antibiotique ceftazidime-avibactam est efficace et bien tol\u00e9r\u00e9e selon une \u00e9tude observationnelle fran\u00e7aise - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png","datePublished":"2025-03-24T16:16:05+00:00","dateModified":"2025-03-26T13:26:10+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/03\/Capture-decran-2025-03-26-103550-768x1024.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/lassociation-dantibiotique-ceftazidime-avibactam-est-efficace-et-bien-toleree-selon-une-etude-observationnelle-francaise\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"L\u2019association d\u2019antibiotique ceftazidime-avibactam est efficace et bien tol\u00e9r\u00e9e selon une \u00e9tude observationnelle fran\u00e7aise"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5","name":"supportmlcom"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-21 20:41:30","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30200"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/275"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=30200"}],"version-history":[{"count":4,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30200\/revisions"}],"predecessor-version":[{"id":30224,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30200\/revisions\/30224"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=30200"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=30200"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=30200"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}